Parks and safety: A comparative study of green space access and inequity in five US cities

TG Williams, TM Logan, CT Zuo, KD Liberman… - Landscape and urban …, 2020 - Elsevier
Safety is an important dimension of access to green space. When parks are perceived as
unsafe, people are unlikely to derive the health and community benefits from them. In this study…

18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages

J Wang, CT Zuo, YP Jiang, YH Guan, ZP Chen… - Journal of …, 2007 - Springer
To investigate the usefulness of 18F-FP-CIT PET for assessing the severity of Parkinson’s
disease (PD) at various clinical stages, 41 patients with PD were divided into early (…

Update on molecular imaging in Parkinson's disease

ZY Liu, FT Liu, CT Zuo, JB Koprich, J Wang - Neuroscience bulletin, 2018 - Springer
Advances in radionuclide tracers have allowed for more accurate imaging that reflects the
actions of numerous neurotransmitters, energy metabolism utilization, inflammation, and …

[HTML][HTML] Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

…, YX Yang, W Xu, HF Wang, L Tan, CT Zuo… - Alzheimer's Research & …, 2021 - Springer
Background Genome-wide association studies have identified more than 30 Alzheimer’s
disease (AD) risk genes, although the detailed mechanism through which all these genes are …

Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression

…, SF Chen, KL Chen, W Cheng, CT Zuo… - Clinical …, 2023 - academic.oup.com
Background Plasma glial fibrillary acidic protein (GFAP) has emerged as a promising biomarker
in neurological disorders, but further evidence is required in relation to its usefulness for …

[HTML][HTML] Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study

…, HQ Li, YX Yang, JH Jiang, M Cui, CT Zuo… - Translational …, 2021 - nature.com
A biological research framework to define Alzheimer’ disease with dichotomized biomarker
measurement was proposed by National Institute on Aging–Alzheimer’s Association (NIA–AA…

Evaluating urban accessibility: leveraging open-source data and analytics to overcome existing limitations

…, AJ Nisbet, KD Liberman, CT Zuo… - … and Planning B …, 2019 - journals.sagepub.com
We revisit the standard methodology for evaluating proximity to urban services and recommend
enhancements to address existing limitations. Existing approaches often simplify their …

[HTML][HTML] Use of radiomic features and support vector machine to distinguish Parkinson's disease cases from normal controls

…, JY Lu, JJ Ge, FT Liu, JT Yu, W Lin, CT Zuo… - Annals of …, 2019 - ncbi.nlm.nih.gov
… Prior to the emission scan, a low-dose CT transmission scan was performed for attenuation
correction. The brain emission scan was acquired between 45 and 55 min after intravenous …

Fe3O4/MXene Nanosphere-Based Microfluidic Chip for the Accurate Diagnosis of Alzheimer's Disease

…, Y Wang, JC Guo, HG Zhou, CT Zuo… - ACS Applied Nano …, 2022 - ACS Publications
Amyloid β protein oligomer (AβO) has been found to be a crucial biomarker of Alzheimer’s
disease (AD). Exploring an accurate detection method of AβO is of great significance for early …

Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: a positron emission tomography study

…, SF Huang, YX Wang, JJ Ge, P Wu, CT Zuo… - Parkinsonism & Related …, 2015 - Elsevier
… Scans were performed with a Siemens Biography 64 PET/CT (Siemens, Germany) in
three-dimensional mode. A CT transmission scan was first performed for attenuation correction. …